Controversies in Thoracic Surgery, An Issue of Thoracic Surgery Clinics, E-Book
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. viii 7. Foreword - p. ix 8. Preface - p. xi 9. Esophageal Perforation: Is Surgery Still Necessary? - p. 117 10. Gastroesophageal Reflux Disease in 2023: When to Operate and Current Endoscopic Options for Antireflux Therapy - p. 125 11. Achalasia: Surgery Versus Per-Oral Endoscopic Myotomy - p. 135 12. Tracheobronchoplasty: Indications and Best Approaches - p. 141 13. Pulmonary Metastasectomy: Indications, Best Practices, and Evolving Role in the Future - p. 149 14. Current Management of Carcinoid Tumor: When Is a Wedge Enough? - p. 159 15. Sublobar Resections: Indications and Approaches - p. 165 16. Stereotactic Body Radiation Therapy Versus Ablation Versus Surgery for Early-Stage Lung Cancer in High-Risk Patients - p. 179 17. Current Management of Stage IIIA (N2) Non-Small-Cell Lung Cancer: Role of Perioperative Immunotherapy, and Tyrosine Kinase Inhibitors - p. 189 18. Neoadjuvant Strategies for Esophageal Cancer: Role of Immunotherapy and Positron emission tomography (PET)-Guided Strategies - p. 197 19. Surgical Approach to Esophagectomy Post CheckMate 577: Do Lymph Nodes Matter if Everyone Gets Adjuvant Immunotherapy? - p. 209
Controversies in Thoracic Surgery, An Issue of Thoracic Surgery Clinics, E-Book
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. viii 7. Foreword - p. ix 8. Preface - p. xi 9. Esophageal Perforation: Is Surgery Still Necessary? - p. 117 10. Gastroesophageal Reflux Disease in 2023: When to Operate and Current Endoscopic Options for Antireflux Therapy - p. 125 11. Achalasia: Surgery Versus Per-Oral Endoscopic Myotomy - p. 135 12. Tracheobronchoplasty: Indications and Best Approaches - p. 141 13. Pulmonary Metastasectomy: Indications, Best Practices, and Evolving Role in the Future - p. 149 14. Current Management of Carcinoid Tumor: When Is a Wedge Enough? - p. 159 15. Sublobar Resections: Indications and Approaches - p. 165 16. Stereotactic Body Radiation Therapy Versus Ablation Versus Surgery for Early-Stage Lung Cancer in High-Risk Patients - p. 179 17. Current Management of Stage IIIA (N2) Non-Small-Cell Lung Cancer: Role of Perioperative Immunotherapy, and Tyrosine Kinase Inhibitors - p. 189 18. Neoadjuvant Strategies for Esophageal Cancer: Role of Immunotherapy and Positron emission tomography (PET)-Guided Strategies - p. 197 19. Surgical Approach to Esophagectomy Post CheckMate 577: Do Lymph Nodes Matter if Everyone Gets Adjuvant Immunotherapy? - p. 209
